SEC Form 4 · accession 0001995535-26-000008
Zura Bio Ltd · ZURA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Parvinder Thiara
Director
Period of report
Jun 17, 2026
Accepted (ET)
Jun 22, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001855644
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy)F1 | $3.62 | Jun 17, 2026 | A | 51,000 | A | — | Jun 17, 2036 | Class A Ordinary Shares | 51,000 | 51,000 | D |
Explanation of responses
- F1This option vests in twelve substantially equal monthly installments over a one-year period measured from June 17, 2026; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date.